From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Medical University of Gdańsk

University

gumed.edu.pl/enGdańsk, Poland
6 profile visits

About

At the Medical University of Gdańsk, we are dedicated to advancing healthcare through education, research, and innovation. Our institution offers a comprehensive range of programs in medicine, dentistry, and pharmacy, empowering aspiring healthcare professionals with the knowledge and skills they need to excel. We pride ourselves on fostering strong collaborations between academic and clinical settings, which enhances our research output and clinical practices. Together, we strive to contribute significantly to the health and wellbeing of our communities and beyond.

Areas of Activity

IHI Topic 1: IHI European healthcare incubator networkIHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studiesIHI Topic 3: Decode the immuno-science of age-related mediated diseasesHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancersHORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypesHORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes researchHORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicinesHORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agenciesOther

Representatives

PROJECT MANAGER

Medical University of Gdańsk